The reduction in prostate cancer deaths in the European Randomized Study of Screening for Prostate Cancer is best explained by a stage migration in the intervention arm, resulting in earlier effective treatment of localized prostate cancer compared with controls.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Carter HB. Are you the author?
James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Reference: Eur Urol. 2014 Jul 10. pii: S0302-2838(14)00625-3.